IP Library Granted Patent US 11,560,364
Granted Patent B2
US 11,560,364 · App. 17/511,432 · Granted Jan 24, 2023

Methods for enriching alpha-tocotrienol from mixed tocol compositions

Inventors: Peter Giannousis (Pacifica, CA); Paul Mollard (San Jose, CA); Noah M. Benjamin (Rancho Cordova, CA); Jeffrey D. Butler (Rancho Cordova, CA); Olivier Dapremont (Rancho Cordova, CA); James B. Falabella (Rancho Cordova, CA)
Assignee: PTC THERAPEUTICS, INC.
C07D311/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,560,364
App. No.
17/511,432
Granted
Jan 24, 2023
Kind
B2
Abstract

Provided herein are methods for making an alpha-tocotrienol enriched tocol mixture, such as from a plant or plant-derived material. Also provided herein are simulated moving bed purification methods for tocotrienol compounds such as alpha tocotrienol.

Claims (37)

1. A method of purifying a tocotrienol from a feed solution comprising the steps of;

a. passing the feed solution through a chromatographic process comprising a stationary phase and a mobile phase stream, wherein said feed solution comprises the tocotrienol and one or more impurity compounds;

b. operating the chromatographic process as a simulated moving bed (SMB) process under conditions effective to purify the tocotrienol from at least one impurity compound;

c. collecting a stream from the SMB apparatus, wherein said stream comprises the purified tocotrienol; and

d. optionally repeating steps a.-c;

wherein the alpha-tocotrienol in the feed stream is prepared according to a method for making an alpha-tocotrienol-enriched tocol mixture, comprising:

(1) contacting a tocol mixture with an amino-alkylating agent, wherein the tocol mixture comprises at least one non-alpha-tocotrienol, at least one non-tocol, optionally alpha-tocotrienol, and optionally one or more tocopherols, whereby the at least one non-alpha-tocotrienol is amino-alkylated;

(2) reducing the amino-alkylated non-alpha-tocotrienols to alpha-tocotrienol with a reducing agent;

(3) removing one or more waxy impurities from the mixture;

(4) contacting the mixture with an agent that binds one or more polar impurities; and

(5) removing the agent that binds one or more polar impurities.

2. The method of claim 1 , wherein the amino-alkylating agent in step (1) comprises a secondary amine and a formaldehyde equivalent.

3. The method of claim 2 , wherein the secondary amine is N-methyl-piperazine.

4. The method of claim 1 , wherein the stream comprising the purified tocotrienol is the extract stream.

5. The method of claim 1 , wherein the stream comprising the purified tocotrienol is the raffinate stream.

6. The method of claim 1 , the stream comprising the purified tocotrienol is the extract stream in a first pass, and wherein the stream comprising the purified tocotrienol is the raffinate stream in a second or subsequent pass.

7. The method of claim 1 , wherein the stream comprising the purified tocotrienol is the raffinate stream in a first pass, and wherein the stream comprising the purified tocotrienol is the extract stream in a second or subsequent pass.

8. The method of claim 1 , wherein the tocotrienol is selected from the group consisting of alpha-tocotrienol, beta-tocotrienol, delta-tocotrienol, and gamma-tocotrienol.

9. The method of claim 8 , wherein the tocotrienol is alpha-tocotrienol.

10. The method of claim 1 , wherein the stationary phase is selected from the group consisting of silica gel, functionalized silica gel, reverse phase gel, or chiral phase gel.

11. The method of claim 1 , wherein the stationary phase has a particle size of about 2 to about 300 μm.

12. The method of claim 1 , wherein the mobile phase stream further comprises one or more solvents selected from the group consisting of: water, acetonitrile, t-AmOH, methanol, ethanol, n-proposal, isopropyl alcohol, butanol, ethyl acetate, isopropyl acetate, MtBE, diethyl ether, fluorinated solvents, alkanes, hexanes, n-hexane, heptanes, n-heptane, methyl-cyclopentane, pentane, methyl-cyclohexane, cyclohexane, toluene, and CO 2 .

13. The method of claim 12 , wherein the mobile phase stream comprises acetonitrile.

14. The method of claim 12 , wherein the mobile phase stream comprises methanol, ethanol, or isopropyl alcohol.

15. The method of claim 1 , wherein the reducing agent in step (2) is sodium cyanoborohydride.

16. The method of claim 1 , wherein a final product stream comprising purified tocotrienol comprises the tocotrienol with at least about 90 (A) % purity.

17. The method of claim 16 , wherein the final product stream comprising purified tocotrienol is concentrated to a tocotrienol concentration of at least about 90 wt %.

18. The method of claim 1 , wherein the chromatographic process comprises 2 to 30 columns serially connected.

19. The method of claim 1 , wherein the chromatographic process is operated at a rate of about 0.05 to about 5 kg feed stream per kg stationary phase per 24 hours.

20. The method of claim 1 , wherein the chromatographic process is operated at a pressure of about 2 bar to about 100 bar.

21. The method of claim 1 , wherein the chromatographic process is operated at a temperature of about 10° C. to about 50° C.

22. The method of claim 1 , wherein the tocol mixture is a palm oil or a material derived from palm oil.

23. The method of claim 1 , further comprising after step (1):

(1)(A) removing water formed from the reaction of step (1).

24. The method of claim 23 , wherein step (1)(A) comprises an azeotropic distillation in the presence of a solvent with a boiling point of at least 95° C. at 1 atm pressure.

25. The method of of claim 24 , wherein the solvent with a boiling point of at least 95° C. at 1 atm pressure is 2-methyl-2-butanol.

26. The method of claim 1 , wherein the solvent of step (2) is 2-methyl-2-butanol.

Assignments (2)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT @ REEL 061803 AND FRAME 0878 Recorded Oct 20, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 065303/0163 →
SECURITY INTEREST Recorded Oct 28, 2022
From: PTC THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 061803/0878 →